- Feb 5, 2002
- 166,616
- 56,250
- Country
- United States
- Faith
- Catholic
- Marital Status
- Married
- Politics
- US-Others
...Symptoms by 79%
An aerosol-based protein inhalant has been shown in trials to reduce the risk of death from SARS-CoV-2 and reduce the chance of developing serious symptoms by 79% compared to patients given a placebo.
Results also showed that patients were more than twice as likely to make a full recovery from Covid-19, meaning they had no lasting respiratory weakness or other damages.
The new drug called SNG001 is an inhalant of the naturally-occurring protein called interferon beta, and arose out of research conducted at the University of Southampton. The British biotech firm Synairgen, co-founded by three of the university’s professors, tested the treatment on 100 hospitalized COVID-19 patients (and 120 who were at home) in a randomized controlled trial spanning a period from March to May.
Continued below.
Possible ‘Breakthrough’ Coronavirus Treatment With Natural Protein Cuts Risk of Death and Serious Symptoms by 79%
An aerosol-based protein inhalant has been shown in trials to reduce the risk of death from SARS-CoV-2 and reduce the chance of developing serious symptoms by 79% compared to patients given a placebo.
Results also showed that patients were more than twice as likely to make a full recovery from Covid-19, meaning they had no lasting respiratory weakness or other damages.
The new drug called SNG001 is an inhalant of the naturally-occurring protein called interferon beta, and arose out of research conducted at the University of Southampton. The British biotech firm Synairgen, co-founded by three of the university’s professors, tested the treatment on 100 hospitalized COVID-19 patients (and 120 who were at home) in a randomized controlled trial spanning a period from March to May.
Continued below.
Possible ‘Breakthrough’ Coronavirus Treatment With Natural Protein Cuts Risk of Death and Serious Symptoms by 79%